At SOHO 2025, Lorenzo Falchi, MD, highlighted the critical role of nurses in monitoring and educating patients on toxicities ...

Michelle Kirschner, MSN, RN, ACNP, APRN-BC, discusses how precision supportive care tailors interventions to patient needs.

The NDA’s acceptance is based on positive data from the phase 3 ROSELLA trial (NCT05257408) as well as from a previous phase ...

Tepotinib was associated with frequent but manageable adverse events in MET exon 14–positive NSCLC, with peripheral edema ...

Formerly known as TAR-200, gemcitabine intravesical system has received the FDA’s approval for use in patients with ...

Other AEs linked to menin inhibitors include cytopenias and mild gastrointestinal symptoms, such as nausea. Still, Issa noted ...